RecruitingNot ApplicableNCT06671119

REvision of VSG with Ablation of the Mucosa Procedure

Sponsor

Dr. Christopher McGowan

Enrollment

5 participants

Start Date

Dec 1, 2024

Study Type

INTERVENTIONAL

Conditions

Obesity and Overweight Obesity Prevention Obesity and Obesity-related Medical Conditions Obesity Recidivism

Summary

The purpose of this study is to evaluate the feasibility, safety, and tolerability of endoscopic selective gastric mucosal ablation (GMA) using argon plasma coagulation after sleeve gastrectomy. In this study, GMA will be performed on patients who have experienced weight regain following an initial successful response to sleeve gastrectomy.

Eligibility

Min Age: 22 YearsMax Age: 60 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Gastric Mucosal Ablation (GMA) for people with obesity prevention, obesity recidivism, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 22 Years to 60 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.